Fig. 3
From: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs
The impact of TRPA1 antagonist treatment in 0.1, 1 and 10 mg.kg−1 BI01305834 doses on airway hyperreactivity (AHR) in response to histamine, defined as PC100pre/PC100post, at t = 6 h, i.e. after the early asthmatic response (EAR). (Veh/Sal = 7 animals, Veh/OA = 10 animals, 0.1/OA = 4 animals, 1/OA = 4 animals, 10/OA = 4 animals)